Archives

April 5, 2020 3:23 pm Published by jonas

Redwood Pharma develops new and improved therapies for DED

April 5, 2020 3:23 pm Published by jonas

Redwood Pharma utvecklar nya & bättre terapier mot DED

Stora Aktiedagen Stockholm 2018 – Redwood Pharma

March 22, 2020 11:22 pm Published by jonas

Aktiedagen Lund 30 januari 2018 – Redwood Pharma

March 22, 2020 11:22 pm Published by jonas

Redwood Pharma comments on the development progress

March 22, 2020 11:21 pm Published by jonas

Aktiedagen i Stockholm – Redwood Pharma

March 22, 2020 11:20 pm Published by jonas

Redwood Pharma

March 22, 2020 11:19 pm Published by jonas

Intervju med Redwood Pharma

March 22, 2020 11:16 pm Published by jonas

Nytt amerikanskt patent för Redwood Pharma – vd berättar

March 22, 2020 11:15 pm Published by jonas

Redwood Pharma #Sitdown

March 22, 2020 11:14 pm Published by jonas

« Previous 1 … 20 21 22 23 24 … 47 Next »

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Redwood Pharma

Vi utvecklar ögonläkemedel för stora medicinska behov. Tonvikten ligger på tidig klinisk utveckling. Den långsiktiga strategin är att teckna licensavtal med andra läkemedelsbolag, som i sin tur kan introducera produkterna på världsmarknaden.